These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 3552595)

  • 41. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imipenem-cilastatin sodium (Primaxin).
    Med Lett Drugs Ther; 1986 Mar; 28(709):29-31. PubMed ID: 3512968
    [No Abstract]   [Full Text] [Related]  

  • 43. Imipenem/cilastatin.
    Lancet; 1988 Aug; 2(8607):376-7. PubMed ID: 2899781
    [No Abstract]   [Full Text] [Related]  

  • 44. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Basic and clinical studies on imipenem/cilastatin sodium in the pediatric field].
    Sunakawa K; Ishizuka Y; Kawai N; Saito N
    Jpn J Antibiot; 1986 Jul; 39(7):1804-16. PubMed ID: 3534346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
    Verbist L; Verpooten GA; Giuliano RA; Debroe ME; Buntinx AP; Entwistle LA; Jones KH
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():115-20. PubMed ID: 3469184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.
    Kim KS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):289-93. PubMed ID: 3087277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fundamental and clinical studies on imipenem/cilastatin sodium in the pediatric field].
    Toyonaga Y; Sugita M; Tsuda T; Takahashi T; Hori M
    Jpn J Antibiot; 1986 Jul; 39(7):1765-86. PubMed ID: 3464778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ocular penetration of N-formimidoyl thienamycin (MK-787) and potentiation by dipeptidase inhibitor (MK-791).
    Finlay KR; Carlson CL; Chow AW
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1147-9. PubMed ID: 6575970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. UTIs and two new antibiotics in the elderly.
    Jones SR; Kimbrough R
    Geriatrics; 1988 Jul; 43(7):49-52, 55-8. PubMed ID: 3290058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency.
    Gibson TP; Demetriades JL; Bland JA
    Am J Med; 1985 Jun; 78(6A):54-61. PubMed ID: 3859216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imipenem/cilastatin for the treatment of infections in hospitalized children.
    Alpert G; Dagan R; Connor E; Campos JM; Bloh AM; Powell KR; Plotkin SA
    Am J Dis Child; 1985 Nov; 139(11):1153-6. PubMed ID: 3904406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An overview of the pharmacology of imipenem/cilastatin.
    Drusano GL
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():79-92. PubMed ID: 3546249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fundamental and clinical studies on imipenem/cilastatin sodium in pediatrics].
    Shiro H; Kusumoto Y; Oikawa T; Osano M
    Jpn J Antibiot; 1986 Jul; 39(7):1787-803. PubMed ID: 3464779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of imipenem-cilastatin in neonates.
    Freij BJ; McCracken GH; Olsen KD; Threlkeld N
    Antimicrob Agents Chemother; 1985 Apr; 27(4):431-5. PubMed ID: 3859242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic and clinical evaluation of imipenem/cilastatin in children and neonates.
    Bégué PC; Baron S; Challier P; Fontaine JL; Lasfargues G
    Scand J Infect Dis Suppl; 1987; 52():40-5. PubMed ID: 3483288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
    Chandrasekar PH; Levine DP; Price S; Rybak MJ
    J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imipenem/cilastatin in the treatment of severe hospital infections.
    Patoia L; Menichetti F; Bucaneve G; Pasticci MB; Baratta E; Grignani F; Del Favero A
    Chemioterapia; 1988 Apr; 7(2):105-8. PubMed ID: 3165056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.